MLT 181 Immunology Chapter 7 Basic Serological Techniques (1)

Chapter 7: Basic Serologic Laboratory Techniques and Clinical Applications

Page 1

  • Title and Copyright Information

    • Created by J. Bullard, MPH, MLS (ASCP)

    • Copyright © 2022, Elsevier Inc.

Page 2: Measurable Student Learning Outcomes

  • Student Learning Outcomes (SLO):

    • State basic immunoassay principles in the serology laboratory (Cognitive Level 1)

    • Perform procedures for testing infectious diseases and immunological disorders (Psychomotor Level 2)

    • Demonstrate principles of safety and quality assurance in immunology testing (Affective Level 2)

    • Explain principles and methodologies for serologic diagnosis of infections and immunological disorders (Cognitive Level 1)

    • Describe standard operating procedures, sample types, glassware, reagents, and test method selection.

Page 3: Building Objectives 1 of 4

  • At the conclusion of this chapter, readers should be able to:

    • Identify the parts of a laboratory procedure (Cognitive Level 1)

    • Describe blood specimen preparation (Cognitive Level 1)

    • Provide examples of specimen types for immunologic procedures (Cognitive Level 1)

    • Explain complement inactivation in serum samples (Cognitive Level 2)

    • Demonstrate pipetting techniques (Cognitive Level 1)

Page 4: Building Objectives 2 of 4

  • Definitions and Comparisons:

    • Define dilution (Cognitive Level 1)

    • Compare acute vs chronic phases of illness (Cognitive Level 3)

    • Define antibody titer (Cognitive Level 1)

Page 5: Building Objectives 3 of 4

  • Differentiation and Discussion:

    • Differentiate testing categories (Cognitive Level 3)

    • Discuss immunology techniques for rapid testing (HIV, malaria, pregnancy) (Cognitive Level 2)

    • Describe clinical applications of one POCT assay (Cognitive Level 1)

    • Analyze case study for assay results interpretation (Cognitive Level 3)

Page 6: Procedures Manual

  • Description:

    • Document of current techniques and approved policies available in the laboratory. Must comply with CLSI format.

Page 7: Blood Specimen Preparation

  • Key Points:

    • Use an anticoagulated evacuated tube; allow to clot based on protocol

    • Transfer serum to labeled tube; testing should occur within 72 hours or frozen at -20°C

    • Heat inactivation may be necessary due to complement interference, which can lead to invalid results.

Page 8: Types of Specimens Tested

  • Main Points:

    • Most assays are conducted using serum, but other body fluids may be used.

    • Lipemia, hemolysis, or bacterial contamination can render specimens unacceptable.

    • Icteric or turbid serum may be valid for some tests but could interfere with others.

Page 9: Inactivation of Complement

  • Process:

    • Inactivation destroys complement activity by heating at 56°C for 30 minutes.

    • Reactivation possible by reheating if > 4 hours post-inactivation.

Page 10: Specimen Integrity

  • Description of Gel Use:

    • Gel density controls separation of blood cells and serum in certain tubes.

Page 11: Pipettes

  • Types Overview:

    • Manual Pipettes: Graduated and serologic pipettes.

    • Semi-Automated Micropipettes for increased efficiency.

Page 12: Manual Pipettes

  • Features:

    • TD: Top Capacity mark, to deliver.

    • Graduated markings for precision in measurement.

Page 13: Automatic Pipettes

  • Description:

    • Allow fast, repetitive measurement of solutions with consistent volume,

    • Include micropipettors, automatic dispensers, and diluter-dispensers.

Page 14: Steps in Using Piston-Type Automatic Micropipette

  • Method:

    • Attach proper tip for the pipette

    • Hold pipette correctly for filling and emptying methods.

Page 15: Diluting Specimens

  • Definition:

    • Dilution Factor: Corrects for using diluted samples.

    • Calculations must multiply result by the reciprocal of the dilution.

    • Serial Dilutions: Further dilutions in a series (e.g., 1 part sample to 1 part diluent).

Page 16: Serial Dilutions

  • Process Diagram:

    • Multiple twofold dilutions illustrated step-by-step.

Page 17: Testing for Antibody Levels

  • Phases of Specimens:

    • Acute Phase: Initial disease detection.

    • Convalescent Phase: Usually assessed about 2 weeks later.

    • Antibody titer measures the highest dilution at which antibodies are detectable.

Page 18: Interpretation of Antibody Titers

  • Clinical Significance:

    • Titer measures evaluate immune status via serial dilutions.

    • The endpoint dilution expresses the titer as a fraction, with the reciprocal representing the titer value.

Page 19: ASO Antibodies

  • Characteristics across Varied Timeline:

    • Peak ASO values and trends over time during infections.

Page 20: Testing Categories

  • Types Overview:

    • Waived Tests: Simple and low-risk.

    • Moderately Complex Tests: Usually automated.

    • Highly Complex Tests: Require significant judgment and skill.

    • Provider-Performed Microscopy Tests: Involving slide examinations.

Page 21: Characteristics of Waived Tests

  • Defined by CLIA 88:

    • Simple methodologies with negligible error likelihood;

    • Minimal patient risk if performed incorrectly;

    • FDA-cleared for home use.

Page 22: Waived Tests Procedures

  • Requirements:

    • Identification of tests to be performed,

    • Procedures for each, confirmatory testing, equipment maintenance, and QC checks.

Page 23: Required Staff Competencies

  • Competency Assessment must be:

    • Conducted at orientation and annually.

    • Include performance on blind specimens and QC monitoring.

Page 24: Malaria Testing

  • Methods:

    • Microscopy: Gold standard; Rapid Device Testing implemented in 2007 mandates confirmation by microscopy.

    • Testing for specific antigens present in infected patients.

Page 28: HIV Testing

  • Settings for Use:

    • Employed in clinics and outreach programs; confirmation with 4th-gen immunoassay required due to lower sensitivity of rapid tests.

Page 29: Pregnancy Testing

  • Development:

    • Early tests were immunoassays; current tests include solid-phase sandwich immunochromatographic assays for hCG detection.

Page 30: Case Study Summary

  • Patient Presentation:

    • 9-year-old boy with sore throat - antistreptolysin-O antibody test ordered.

    • Throat culture confirmed streptococci and positive ASO results; both acute and convalescent serum specimens prepared for titer testing.

Page 31: ASO Test Results Demonstration

  • Parallel Testing Results:

    • Acute specimen: Positive at 1:1 dilution; Convalescent: Positive at 1:4 dilution.

Page 32: ASO Questions

  • Sample Questions:

    1. What did the convalescent specimen demonstrate regarding streptococci infection?

    2. How can comparing acute and chronic specimens aid diagnosis?